A potential gene candidate involved in dopaminergic neurotransmission might be the PIP4K2A (phosphatidylinositol-5-phosphate-4-kinase type 2 α), which has been associated with the risk of schizophrenia, as well as tardive dyskinesia [14,15,16,17]. This evidence concerns the gene PIP4K2A and schizophrenia.